Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
76.20
+2.18 (2.95%)
Jan 30, 2025, 4:00 PM EST - Market closed
PRAX Employees
Praxis Precision Medicines had 82 employees as of December 31, 2023. The number of employees decreased by 27 or -24.77% compared to the previous year.
Employees
82
Change (1Y)
-27
Growth (1Y)
-24.77%
Revenue / Employee
$19,573
Profits / Employee
-$1,841,683
Market Cap
1.47B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 82 | -27 | -24.77% |
| Dec 31, 2022 | 109 | -30 | -21.58% |
| Dec 31, 2021 | 139 | 72 | 107.46% |
| Dec 31, 2020 | 67 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
PRAX News
- 18 days ago - Praxis Precision Medicines Highlights 2025 Corporate Strategy and Business Priorities - GlobeNewsWire
- 6 weeks ago - Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted for Relutrigine in Dravet Syndrome - GlobeNewsWire
- 2 months ago - GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients with New Partners - Business Wire
- 2 months ago - Praxis Precision Medicines to Present at Upcoming December Investor Conferences - GlobeNewsWire
- 3 months ago - Praxis Precision Medicines to Participate in Three Upcoming November Investor Conferences - GlobeNewsWire
- 3 months ago - Praxis Precision Medicines, Inc. (PRAX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Praxis Precision Medicines to Announce Third Quarter 2024 Financial Results and Host Conference Call on Wednesday, November 6, 2024 - GlobeNewsWire